Getting Ophthalmic Biosimilars to Market Continues to Prove

Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have during a session at AMCP 2023.

Related Keywords

Indiana , United States , New York , North Carolina , American , Sneha Sharma , Prerak Parikh , American Academy Of Ophthalmology , American Society Of Retina Specialists , National Drug Code , Addressing Drug Trends , Managed Care Strategies , Magellan Rx Management , American Academy , American Society , Healthcare Common Procedure Coding System , Dme , Amd , Biosimilars , Magellan Rx , Avastin , Lucentis ,